Tested Applications
| Positive WB detected in | DU 145 cells |
| Positive IHC detected in | human colon cancer tissue, human prostate cancer tissue, human testis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:2000 |
| Immunohistochemistry (IHC) | IHC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
26001-1-AP targets SRD5A1 in WB, IHC, IF, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag23351 Product name: Recombinant human SRD5A1 protein Source: e coli.-derived, PET28a Tag: 6*His Domain: 1-163 aa of BC007033 Sequence: MATATGVAEERLLAALAYLQCAVGCAVFARNRQTNSVYGRHALPSHRLRVPARAAWVVQELPSLALPLYQYASESAPRLRSAPNCILLAMFLVHYGHRCLIYPFLMRGGKPMPLLACTMAIMFCTCNGYLQSRYLSHCAVYADDWVTDPRFLIGFGLWLTGML Predict reactive species |
| Full Name | steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) |
| Observed Molecular Weight | 29 kDa |
| GenBank Accession Number | BC007033 |
| Gene Symbol | SRD5A1 |
| Gene ID (NCBI) | 6715 |
| RRID | AB_2880328 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | P18405 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Background Information
Steroid 5-alpha-reductase (SRD5A1) catalyzes the conversion of 17β-Hydroxyandrost-4-en-3-one into the more potent androgen, DHT. SRD5A1 is a minor component of the reductase activity in prostate although the gene was originally cloned from prostate. On the other hand, SRD5A1 appears to be the predominant isozyme of steroid 5-alpha-reductase in the scalp and elsewhere in the skin.
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for SRD5A1 antibody 26001-1-AP | Download protocol |
| WB protocol for SRD5A1 antibody 26001-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The SRD5A1 Polyclonal antibody (Cat# 26001-1-AP) has 9 citations published in journals including Cell, Advanced Science, Cells, Journal of Integrative Medicine, Scientific Reports, Biomedicines, Reproductive Biomedicine Online, Cancer Medicine, and Journal of Steroid Biochemistry and Molecular Biology. Research fields span androgen receptor biology, polycystic ovary syndrome, benign prostatic hyperplasia, steroidogenic pathways, cervical remodeling, and lung adenocarcinoma. Applications include WB, IHC, and IF.
| Species | Application | Title |
|---|---|---|
Adv Sci (Weinh) Hepatic KLF9 Deficiency Inhibits Dehydroepiandrosterone (DHEA)-Induced Polycystic Ovary Syndrome via Liver-Ovary Axis. | ||
Cells Promegestone Prevents Lipopolysaccharide-Induced Cervical Remodeling in Pregnant Mice | ||
J Integr Med Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by reducing expression of androgen receptor and 5α-reductase in a rat model. | ||
Sci Rep Pao Pereira Extract Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by inhibiting 5α-Reductase. | ||
Biomedicines Mixed-Culture Propagation of Uterine-Tissue-Resident Macrophages and Their Expression Properties of Steroidogenic Molecules |













